Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
A significant and inverse correlation between GAS5 and IL-18 was found in RA patients but not in healthy controls.
|
31372853 |
2019 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The secreted IL-18 was also elevated in HUVECs but not in RA FLS.
|
31119302 |
2019 |
Rheumatoid Arthritis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
IL-18 levels for RA with ILD and RA without ILD were compared.
|
30269670 |
2019 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Moreover, MA could effectively stimulate the innate immune cytokines (IL-1[Formula: see text], IL-1[Formula: see text], IL-6, IL-7, IL-18, TNF-[Formula: see text]) and adaptive immunity cytokines (IL-2, IL-12, IFN-[Formula: see text], IL-4, IL-5, IL-10, IL-13, IL-17) as the main part of the immune response and repaired damage of RA.
|
30001644 |
2018 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
IL-18 plays an important role in host innate and adaptive immune defense but its aberrant activities are also associated with inflammatory diseases such as rheumatoid arthritis and Crohn's disease.
|
28352119 |
2017 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In summary, the current meta-analysis, which was based on the most current studies, showed that the -607A/C, -920C/T, and -105A/C polymorphisms in IL-18 were significantly associated with increased RA risk.
|
26909913 |
2016 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
IL-18BP is a natural antagonist of pro-inflammatory IL-18 cytokine linked to autoimmune disorders like rheumatoid arthritis.
|
27649785 |
2016 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our finds suggest a possible role for IL-18 polymorphism in the RA susceptibility in studied population.
|
26302971 |
2015 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
For example, IL-1β and IL-18 further perpetuate Th17 responses and endothelial cell damage, which potentiate a number of autoimmune diseases, including synovitis in RA, cardiovascular disease, and systemic lupus erythematosus (SLE).
|
26005048 |
2015 |
Rheumatoid Arthritis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Caspase-1 and interleukin-18 levels were significantly raised in patients with RA.
|
23687262 |
2014 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This meta-analysis indicates that IL-18 -607A/C polymorphism in promoter region may be associated with RA risk.
|
25192895 |
2014 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
In the present review, we focus on IL-7, IL-18, IL-32 and IL-10 family of cytokines (IL-19, IL-20 and IL-22) as they are implicated in contributing to the pathogenesis of RA, which could be targeted and offer new therapeutic options for RA therapy.
|
24437572 |
2014 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
IL-18 -137G/C could increase the risk of RA and SLE.
|
23914907 |
2014 |
Rheumatoid Arthritis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
IL-18 is highly expressed in sera, synovial fluids and synovial tissues of patients with RA, and these IL-18 levels are correlated with RA disease activity, indicating an important role of IL-18 in the pathogenesis of RA.
|
23587914 |
2013 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This meta-analysis demonstrates that the IL-4 -590 T/C polymorphism is associated with susceptibility to RA in Europeans, but the IL-4R + 1902 G/A, IL-18 -607 C/A and -137 G/C polymorphisms are not associated with RA.
|
23883285 |
2013 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
The aim of the present study was to elucidate whether IL-18 has any indirect effects on osteoclastogenesis by regulating the production of molecules from fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA).
|
22945280 |
2013 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Association of the polymorphisms of the IL-18 gene was found with neither RA nor risk factors for CVD, including cholesterol level and CRP (P > 0.05).
|
23856797 |
2013 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
For the relationship between IL-18 rs187238 polymorphism and RA or SLE, there was no significant association detected in all genetic models, even in Chinese population.
|
23153245 |
2012 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This study investigates the association between IL-18 promoter polymorphisms and RA susceptibility.
|
21225442 |
2011 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In contrast, allelic and genotypic frequencies of IL-18-607 did not show significant difference between RA patients and normal subjects (P>0.05) or between anti-CCP-positive and anti-CCP-negative RA patients (P>0.05).
|
20424918 |
2011 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Monocyte recruitment to rhuIL-18 was then tested in vivo by using an RA synovial tissue (ST) severe combined immunodeficient (SCID) mouse chimera.
|
20565717 |
2010 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The aim of the present study was to examine the IL18 promoter polymorphism in patients with RA in association with disease susceptibility and activity.
|
19229765 |
2009 |
Rheumatoid Arthritis
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Moreover, we also demonstrated that miR-346 indirectly regulated IL-18 release by indirectly inhibiting LPS-induced Bruton's tyrosine kinase expression in LPS-activated RA FLS.
|
19342689 |
2009 |
Rheumatoid Arthritis
|
0.400 |
Biomarker
|
disease |
BEFREE |
Inhibitory effect of triptolide on interleukin-18 and its receptor in rheumatoid arthritis synovial fibroblasts.
|
18516710 |
2008 |
Rheumatoid Arthritis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
An IL-18 genetic A/C polymorphism at coding position 105 (rs549908) has been linked with asthma and rheumatoid arthritis.
|
18250135 |
2008 |